Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Leading New Zealand cancer research 'super-charged' by data privacy startup 2023-05-25 21:00
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease 2023-05-25 19:00
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology 2023-05-25 19:00
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow 2023-05-25 14:05
TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I 2023-05-25 09:51
Clarity's theranostic prostate cancer trial advances to cohort 2 2023-05-24 21:03
BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 2023-05-24 16:14
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-05-23 20:00
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study 2023-05-23 19:00
Introducing Ceretone's Core One: The Revolutionary OTC Hearing Aid Launching on Indiegogo in May 2023-05-23 18:01
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History 2023-05-23 14:00
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics 2023-05-23 13:00
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin's Lymphoma 2023-05-23 00:00
HanX Biopharmaceuticals announces HX009 IND approval from FDA 2023-05-22 22:00
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102 2023-05-21 22:23
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023 2023-05-19 20:00
2023 Qingdao∙ Global Venture Capital Conference Comes to a Close 2023-05-19 20:00
1 78 79 80 81 82 431